Aquamin® for Ulcerative Colitis
Recruiting0 awardsPhase 2
Ann Arbor, Michigan
This trial is testing Aquamin®, a seaweed-based supplement rich in minerals, to see if it can help people with mild Ulcerative Colitis feel better and stay symptom-free. The study focuses on patients who have mild symptoms or are already in remission. The idea is that the minerals in Aquamin® might reduce gut inflammation.
Monoclonal Antibodies
Mirikizumab for Ulcerative Colitis
Recruiting2 awardsPhase 3
Dothan, Alabama
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Monoclonal Antibodies
Risankizumab for Ulcerative Colitis
Recruiting1 awardPhase 3
Coronado, California
This trial will assess the safety and efficacy of risankizumab as a treatment for ulcerative colitis. The study will last for 52 weeks and will compare the results of those taking risankizumab to those taking a placebo.
Popular Filters
Trials for ASC Patients
Behavioural Intervention
Digital Care for Inflammatory Bowel Disease
Recruiting0 awards1 criteria
San Diego, California
This trial aims to see if patients with Inflammatory Bowel Disease (IBD) have better outcomes and feel more empowered if they can communicate with their clinical team through text messages and have their symptoms monitored
Microbiota Therapy
RMT for Colitis
Recruiting0 awardsPhase 2
Minneapolis, Minnesota
This trial is testing a new treatment for immune-related colitis caused by drugs used to treat cancer. The treatment involves restoring gut microbial diversity, and aims to improve the quality of life for those affected.
Monoclonal Antibodies
Infliximab vs Vedolizumab for Colitis from Immunotherapy in Cancer Patients
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing the side effects of two drugs, infliximab and vedolizumab, to treat colitis caused by immunotherapy in patients with genital or urinary cancer or melanoma.
Microbiota Therapy
Fecal Microbiota Transplantation for Genitourinary Cancers
Recruiting3 awardsPhase 1
Houston, Texas
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis caused by certain medications. Fecal microbiota transplantation may reduce the incidence of these conditions.
Janus Kinase (JAK) Inhibitor
Long-Term Filgotinib for Ulcerative Colitis
Recruiting1 awardPhase 3
Dothan, Alabama
This trial aims to observe the safety of filgotinib in adults with ulcerative colitis who were part of an earlier study. Filgotinib reduces inflammation by blocking certain proteins. The goal is to ensure it is safe for extended use.
Trials for Ulcerative Colitis Patients
Microbiota Therapy
RMT for Colitis
Recruiting0 awardsPhase 2
Minneapolis, Minnesota
This trial is testing a new treatment for immune-related colitis caused by drugs used to treat cancer. The treatment involves restoring gut microbial diversity, and aims to improve the quality of life for those affected.
Monoclonal Antibodies
Infliximab vs Vedolizumab for Colitis from Immunotherapy in Cancer Patients
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing the side effects of two drugs, infliximab and vedolizumab, to treat colitis caused by immunotherapy in patients with genital or urinary cancer or melanoma.
Microbiota Therapy
Fecal Microbiota Transplantation for Genitourinary Cancers
Recruiting3 awardsPhase 1
Houston, Texas
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis caused by certain medications. Fecal microbiota transplantation may reduce the incidence of these conditions.
Phase 3 Trials
Janus Kinase (JAK) Inhibitor
Long-Term Filgotinib for Ulcerative Colitis
Recruiting1 awardPhase 3
Dothan, Alabama
This trial aims to observe the safety of filgotinib in adults with ulcerative colitis who were part of an earlier study. Filgotinib reduces inflammation by blocking certain proteins. The goal is to ensure it is safe for extended use.
Janus Kinase (JAK) Inhibitor
Oral Tofacitinib for Ulcerative Colitis in Children
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is designed to see if tofacitinib is effective in treating pediatric UC patients who have either failed or been intolerant to other treatments. The primary objective is to see if the patients go into remission after 44 weeks of treatment.
Monoclonal Antibodies
Guselkumab for Ulcerative Colitis
Recruiting0 awardsPhase 2 & 3
Lancaster, California
This trial is testing guselkumab, a medication that targets inflammation, in patients with moderate to severe ulcerative colitis. Guselkumab works by attaching to a protein to reduce inflammation in the colon. This medication has shown promise in treating conditions like ulcerative colitis.
Trials With No Placebo
Monoclonal Antibodies
Infliximab vs Vedolizumab for Colitis from Immunotherapy in Cancer Patients
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing the side effects of two drugs, infliximab and vedolizumab, to treat colitis caused by immunotherapy in patients with genital or urinary cancer or melanoma.
Microbiota Therapy
Fecal Microbiota Transplantation for Genitourinary Cancers
Recruiting3 awardsPhase 1
Houston, Texas
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis caused by certain medications. Fecal microbiota transplantation may reduce the incidence of these conditions.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.